FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to application of binuclear sulphur-nitrosyl complex of anion type iron of formula Na2[Fe2(S2O3)2(NO)4]·4H2O as vasodepressor means for obtaining medication for treatment of ischemic diseases.
EFFECT: invention ensures extension of arsenal of cardiotropic medications with improved activity spectrum based on said iron complex, which is non-toxic water-soluble NO donor.
2 cl, 4 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF BINUCLEAR SULPHUR-NITROSYL CATIONIC IRON COMPLEX AS VASODILATATOR | 2010 |
|
RU2460531C2 |
| BINUCLEAR NITROSYL IRON COMPLEXES WITH BENZAZEHETEROCYCLIC DERIVATIVES, WAYS OF ITS PRODUCTION | 2007 |
|
RU2441872C2 |
| USING TETRANITROSYL COMPLEX OF IRON WITH THIOPHENOL AS ANTI-TUMOUR MEDICINAL AGENT | 2007 |
|
RU2429242C2 |
| DODECAPEPTIDES HAVING CARDIOPROTECTIVE PROPERTIES | 2010 |
|
RU2457216C1 |
| METHOD OF OPTIMAL HYDRAULIC DILATATION IN PROCESS OF PREPARATION OF AUTOVENOUS CONDUITS IN OPERATIONS OF CORONARY BYPASS SURGERY | 2017 |
|
RU2661735C1 |
| WATER-SOLUBLE BINUCLEAR CATION NITROSYL IRON COMPLEXES WITH NATURAL ALIPHATIC THIOLYLS POSSESSING CYTOTOXIC, APOPTOTIC AND NO-DONOR ACTIVITY | 2008 |
|
RU2441873C2 |
| METHOD OF DELIBERATE CARDIAC ARREST BEFORE AORTIC COMPRESSION IN CARDIAC SURGERIES EMPLOYING EXTRACORPOREAL CIRCULATION IN PATIENTS WITH AORTIC VALVE INCOMPETENCE | 2010 |
|
RU2432186C1 |
| MONONECLEAR DINITROSYL FERRIC COMPLEXES, METHOD FOR PREPARING MONONECLEAR DINITROSYL FERRIC COMPLEXES, NITROGEN MONOXIDE DONOR, USING MONONECLEAR DINITROSYL FERRIC COMPLEXES AS ANTI-TUMOUR DRUG | 2011 |
|
RU2494104C2 |
| METHOD OF CARDIOPLEGIC ANTEGRADE MYOCARDIAL PROTECTION | 2022 |
|
RU2803867C1 |
| METHOD FOR TREATING THE CASES OF ACUTE CARDIAC INSUFFICIENCY | 2001 |
|
RU2200481C2 |
